Annual EPS
$3.66$2.07+130.33%
Summary
- Current Value
- As of today, GSK annual EPS is $3.66, up +130.33% on
- Historical Performance
- GSK annual EPS is down -59.44% over the past 3 years, and up +0.03% over the past 5 years
- All-Time High Comparison
- GSK annual EPS is currently -59.44% below its historical high of $9.02 set on
- 3-Year Low Comparison
- GSK annual EPS is +130.33% above its 3-year low of $1.59 reached on
- Sector Comparison
- GSK annual EPS is higher than 94.45% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate GSK annual EPS at $4.81, +31.57% higher than the current value
- Upcoming Earnings
- As of today, the next annual earnings release for GSK has not been scheduled
EPS Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EPS | $3.66 | +130.3% | -59.4% | +0.0% | +197.3% | |
| Quarterly EPS | $0.41 | +61.5% | -51.7% | -6.6% | +178.5% | |
| TTM EPS | $3.66 | +131.6% | -58.3% | +0.8% | +195.3% | |
| Price | $59.01 | +61.8% | +64.7% | +62.9% | +51.8% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% | |
| PE Ratio | 16.11 | -30.1% | +294.9% | +61.6% | -48.6% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% | |
| Annual Gross Profit | $31.23B | +11.6% | +30.3% | +5.3% | -2.1% | |
| Shares Outstanding | 2.02B | -1.0% | -1.3% | +0.4% | – |
EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.02 | N/A | -59.4% |
| 5Y | $9.02 | -59.4% | |
| All | $9.02 | -59.4% |
EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.59 | +130.3% | |
| 5Y | $1.59 | +130.3% | |
| All | $0.63 | +484.8% |
EPS Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.92 | $1.59 | -59.44% | |
| $4.50 | $3.66 | -18.72% | |
| $4.81 | N/A | +31.57% | |
| $5.15 | N/A | +40.75% |
🔒 Log In To Unlock Full Data
EPS History
FAQ
What is the current annual EPS of GSK?
As of today, GSK annual EPS is $3.66
What is 1-year change in GSK annual EPS?
GSK annual EPS is up +130.33% year-over-year
What is 3-year change in GSK annual EPS?
GSK annual EPS is down -59.44% over the past 3 years
How far is GSK annual EPS from its all-time high?
GSK annual EPS is currently -59.44% below its historical high of $9.02 set on December 31, 2022
How does GSK annual EPS rank versus sector peers?
GSK annual EPS is higher than 94.45% of companies in Healthcare sector
How does the analyst estimate for GSK annual EPS compare to its current value?
Analysts estimate GSK annual EPS at $4.81, +31.57% higher than the current value
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly EPS
$0.41$0.91-68.72%
Summary
- Current Value
- As of today, GSK quarterly EPS is $0.41, down -68.72% on
- Historical Performance
- GSK quarterly EPS is up +61.53% year-over-year, and down -51.71% over the past 3 years
- All-Time High Comparison
- GSK quarterly EPS is currently -93.41% below its historical high of $6.28 set on
- 3-Year Low Comparison
- GSK quarterly EPS is +1218.92% above its 3-year low of -$0.04 reached on
- Sector Comparison
- GSK quarterly EPS is higher than 87.85% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate GSK quarterly EPS at $1.18, +184.28% higher than the current value
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EPS | $0.41 | -68.7% | +61.5% | -51.7% | -6.6% | |
| Annual EPS | $3.66 | – | +130.3% | -59.4% | +0.0% | |
| TTM EPS | $3.66 | +4.5% | +131.6% | -58.3% | +0.8% | |
| Price | $59.01 | +24.6% | +61.8% | +64.7% | +62.9% | |
| Quarterly Revenue | $11.46B | -0.6% | +10.2% | +32.5% | -0.7% | |
| PE Ratio | 16.11 | +19.3% | -30.1% | +294.9% | +61.6% | |
| Quarterly Net Income | $966.83M | -66.6% | +50.6% | -49.3% | -12.7% | |
| Quarterly Gross Profit | $7.95B | -6.5% | +11.2% | +30.9% | +4.4% | |
| Shares Outstanding | 2.02B | – | -1.0% | -1.3% | +0.4% |
Quarterly EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.32 | -68.7% | |
| 3Y | $1.32 | -68.7% | |
| 5Y | $6.23 | -93.3% | |
| All | $6.28 | -93.4% |
Quarterly EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.26 | N/A | +61.5% |
| 3Y | -$0.04 | +1218.9% | |
| 5Y | -$0.04 | +1218.9% | |
| All | -$0.53 | +178.5% |
Quarterly EPS Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.26 | $1.32 | +4.87% | |
| $0.62 | $0.41 | -33.65% | |
| $1.18 | N/A | +184.28% | |
| $1.25 | N/A | +201.96% |
🔒 Log In To Unlock Full Data
Quarterly EPS History
FAQ
What is the current quarterly EPS of GSK?
As of today, GSK quarterly EPS is $0.41
What is GSK quarterly EPS most recent change?
GSK quarterly EPS was down -68.72% on December 31, 2025
What is 1-year change in GSK quarterly EPS?
GSK quarterly EPS is up +61.53% year-over-year
How far is GSK quarterly EPS from its all-time high?
GSK quarterly EPS is currently -93.41% below its historical high of $6.28 set on March 31, 2015
How does GSK quarterly EPS rank versus sector peers?
GSK quarterly EPS is higher than 87.85% of companies in Healthcare sector
How does the analyst estimate for GSK quarterly EPS compare to its current value?
Analysts estimate GSK quarterly EPS at $1.18, +184.28% higher than the current value
When is GSK next earnings release?
The next earnings release for GSK is on
TTM EPS
$3.66$0.16+4.50%
Summary
- Current Value
- As of today, GSK TTM EPS is $3.66, up +4.50% on
- Historical Performance
- GSK TTM EPS is up +131.55% year-over-year, and down -58.32% over the past 3 years
- All-Time High Comparison
- GSK TTM EPS is currently -59.13% below its historical high of $8.96 set on
- 3-Year Low Comparison
- GSK TTM EPS is +138.39% above its 3-year low of $1.54 reached on
- Sector Comparison
- GSK TTM EPS is higher than 93.83% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate GSK TTM EPS at $3.85, +5.14% higher than the current value
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EPS | $3.66 | +4.5% | +131.6% | -58.3% | +0.8% | |
| Quarterly EPS | $0.41 | -68.7% | +61.5% | -51.7% | -6.6% | |
| Annual EPS | $3.66 | – | +130.3% | -59.4% | +0.0% | |
| Price | $59.01 | +24.6% | +61.8% | +64.7% | +62.9% | |
| TTM Revenue | $43.11B | +2.5% | +7.5% | +19.1% | -1.5% | |
| PE Ratio | 16.11 | +19.3% | -30.1% | +294.9% | +61.6% | |
| TTM Net Income | $8.29B | +4.1% | +121.4% | +35.1% | +1.9% | |
| TTM Gross Profit | $31.27B | +2.6% | +8.8% | +27.8% | +5.6% | |
| Shares Outstanding | 2.02B | – | -1.0% | -1.3% | +0.4% |
TTM EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.66 | at high | |
| 3Y | $8.96 | -59.1% | |
| 5Y | $8.96 | -59.1% | |
| All | $8.96 | -59.1% |
TTM EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.58 | N/A | +131.6% |
| 3Y | $1.54 | +138.4% | |
| 5Y | $1.54 | +138.4% | |
| All | $0.00 | N/A |
TTM EPS History
FAQ
What is the current TTM EPS of GSK?
As of today, GSK TTM EPS is $3.66
What is GSK TTM EPS most recent change?
GSK TTM EPS was up +4.50% on December 31, 2025
What is 1-year change in GSK TTM EPS?
GSK TTM EPS is up +131.55% year-over-year
How far is GSK TTM EPS from its all-time high?
GSK TTM EPS is currently -59.13% below its historical high of $8.96 set on June 30, 2023
How does GSK TTM EPS rank versus sector peers?
GSK TTM EPS is higher than 93.83% of companies in Healthcare sector
How does the analyst estimate for GSK TTM EPS compare to its current value?
Analysts estimate GSK TTM EPS at $3.85, +5.14% higher than the current value
When is GSK next earnings release?
The next earnings release for GSK is on
EPS Formula
EPS =
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1131399/000165495426000892/0001654954-26-000892-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk